Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group.
Wimberger P, Pfisterer J, du Bois A, Hilpert F, Kerkmann M, Sehouli J, Mahner S, de Gregorio N, Hanker L, Heitz F, Marmé F, Woelber L, Holtmann L, Elser G, Harter P; AGO Study Group.
Wimberger P, et al. Among authors: kerkmann m.
Int J Gynecol Cancer. 2023 Jul 3;33(7):1083-1089. doi: 10.1136/ijgc-2022-004233.
Int J Gynecol Cancer. 2023.
PMID: 37001891